sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Pruritus Therapeutics Market [By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others); By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others); and By Regions]: Market size & Forecast, 2018 - 2026

Global Pruritus Therapeutics Market [By Product (Corticosteroids, Antihistamines, Local Anesthetics,...

Home / Categories / Healthcare
Global Pruritus Therapeutics Market [By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others); By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others); and By Regions]: Market size & Forecast, 2018 - 2026
Global Pruritus Therapeutics Market [By...
Report Code
RO1/107/1037

Publish Date
01/May/2018

Pages
90
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Pruritus Therapeutics Market Insights
3.1. Pruritus Therapeutics– Industry snapshot
3.2. Pruritus Therapeutics- Ecosystem analysis
3.3. Pruritus Therapeutics Market dynamics
3.3.1. Pruritus Therapeutics– Market Forces
3.3.1.1. Pruritus Therapeutics Market driver analysis
3.3.1.2. Pruritus Therapeutics Market restraint/challenges analysis
3.3.1.3. Pruritus Therapeutics Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Pruritus Therapeutics Market PEST analysis, 2017
3.5.1. Pruritus Therapeutics Industry trends
3.5.2. Competitive Ranking Analysis
4. Pruritus Therapeutics Market Size and Forecast by Product
4.1. Key findings
4.2. Corticosteroids
4.2.1. Global market estimates and forecasts, 2017 – 2026
4.3. Antihistamines
4.3.1. Global market estimates and forecasts, 2017 – 2026
4.4. Local Anesthetics
4.4.1. Global market estimates and forecasts, 2017 – 2026
4.5. Counterirritants
4.5.1. Global market estimates and forecasts, 2017 – 2026
4.6. Immunosuppressant
4.6.1. Global market estimates and forecasts, 2017 – 2026
4.7. Calcineurin Inhibitors
4.7.1. Global market estimates and forecasts, 2017 – 2026
4.8. Others
4.8.1. Global market estimates and forecasts, 2017 – 2026
5. Pruritus Therapeutics Market Size and Forecast by Disease Type
5.1. Key findings
5.2. Atopic Dermatitis
5.2.1. Global market estimates and forecasts, 2017 - 2026
5.3. Allergic Contact Dermatitis
5.3.1. Global market estimates and forecasts, 2017 - 2026
5.4. Urticaria
5.4.1. Global market estimates and forecasts, 2017 - 2026
5.5. Others
5.5.1. Global market estimates and forecasts, 2017 - 2026
6. Pruritus Therapeutics Market Size and Forecast by Regions
6.1. Key findings
6.2. North America
6.2.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.2.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.2.3. U.S.
6.2.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.2.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.2.4. Canada
6.2.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.2.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.3. Europe
6.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.3.3. Germany
6.3.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.3.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.3.4. UK
6.3.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.3.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.3.5. France
6.3.5.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.3.5.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.3.6. Italy
6.3.6.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.3.6.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.4. Asia Pacific
6.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.4.3. China
6.4.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.4.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.4.4. India
6.4.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.4.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.4.5. Japan
6.4.5.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.4.5.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.4.6. Australia
6.4.6.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.4.6.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.5. Latin America
6.5.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.5.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.5.3. Brazil
6.5.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.5.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.5.4. Mexico
6.5.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.5.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
6.6. Middle East & Africa
6.6.1. Pruritus Therapeutics Market by Product, 2017 - 2026
6.6.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026
7. Company Profiles
7.1. Allergan Inc.
7.1.1. Overview
7.1.2. Financials
7.1.3. Product Benchmarking
7.1.4. Recent Developments
7.2. Amgen Inc.
7.2.1. Overview
7.2.2. Financials
7.2.3. Product Benchmarking
7.2.4. Recent Developments
7.3. Astellas Pharma Inc.
7.3.1. Overview
7.3.2. Financials
7.3.3. Product Benchmarking
7.3.4. Recent Developments
7.4. CARA Therapeutics
7.4.1. Overview
7.4.2. Financials
7.4.3. Product Benchmarking
7.4.4. Recent Developments
7.5. Novartis AG
7.5.1. Overview
7.5.2. Financials
7.5.3. Product Benchmarking
7.5.4. Recent Developments
7.6. Teva Pharmaceutical Industries Ltd.
7.6.1. Overview
7.6.2. Financials
7.6.3. Product Benchmarking
7.6.4. Recent Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com